Afluria: Clinical Trials

2 trials of Afluria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Afluria: new trials by email Literature Review of Afluria trials Research Report on Afluria

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age
Flublok, Afluria - Influenza
Phase 3CompletedProtein Sciences Corporation26402013-03-012015-02-18
A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population
CSL's Influenza Virus Vaccine (Afluria), Influenza Virus Vaccine (Fluzone) - Influenza
Phase 3CompletedSeqirus14742009-09-012017-05-16

Conditions studied

Influenza, Human (2)

Sponsors

Protein Sciences Corporation (1)  ·  Seqirus (1)

Countries

United States (2)

Top investigators

Alan C. Wine, MD (1)  ·  Bob Weiss, MD (1)  ·  Brandon Essink, MD (1)  ·  Darrell Herrington, DO (1)  ·  Eric Sheldon (1)  ·  Frank Eder, MD (1)  ·  George Bauer, MD (1)  ·  Jeffrey Rosen, MD (1)  ·  Joe Blumenau, MD (1)  ·  Leah Schmidt, DO (1)  ·  Paul Bradley, MD (1)  ·  Steven Folkerth, MD (1)  ·  Terry Poling, MD (1)  ·  Treva Tyson, MD (1)

Results publications

PMID 25454878, PMID 26529070